हिंदी में पढ़ें

Glenmark Pharmaceuticals

Glenmark Pharmaceuticals PAT at Rs 354.49 crore in September quarter

Glenmark Pharmaceuticals PAT at Rs 354.49 crore in September quarter

Thu, Nov 14, 2024

Glenmark Pharmaceuticals Ltd on Thursday reported a consolidated profit after tax of Rs 354.49 crore in the second quarter ended on September 30, 2024.

Glenmark unit ties up with BeiGene to market cancer drugs in India

Glenmark unit ties up with BeiGene to market cancer drugs in India

Tue, May 21, 2024

As per the collaboration, Glenmark will be responsible for locally required development, registration and distribution providing access to the two medicines for cancer patients across India.

Glenmark inks distribution, licensing pacts with Cosmo for acne treatment ointment

Glenmark inks distribution, licensing pacts with Cosmo for acne treatment ointment

Wed, Sep 27, 2023

Glenmark Pharmaceuticals Ltd announced signing of distribution and licence agreements with Cosmo Pharmaceuticals NV for acne treatment ointment Winlevi for Europe and South Africa.

TRENDING NOW

Glenmark gets USFDA nod for generic Tacrolimus ointment

Glenmark gets USFDA nod for generic Tacrolimus ointment

Thu, Aug 17, 2023

Glenmark Pharma news: Glenmark Pharmaceuticals Ltd on Thursday said it has received approval from the US health regulator for its generic Tacrolimus ointment indicated for the treatment of moderate to severe atopic dermatitis.

Glenmark Pharma Q1 Results: Net profit falls 18% to Rs 173.13 crore

Glenmark Pharma Q1 Results: Net profit falls 18% to Rs 173.13 crore

Sat, Aug 12, 2023

Glenmark Pharmaceuticals Ltd on Friday reported an 18 per cent decline in consolidated net profit at Rs 173.13 crore in the first quarter ended June 30, 2023, impacted by higher expenses.

Glenmark Pharmaceuticals Settles Generic Drug 'Zetia' Case In US, Watch Details Here

Glenmark Pharmaceuticals Settles Generic Drug 'Zetia' Case In US, Watch Details Here

Wed, Apr 19, 2023

Glenmark Pharmaceuticals has settled a generic drug 'Zetia' case in the US. Watch to know the complete details in this video.

Q3 Results: How Will Be The Results Of Glenmark Pharmaceuticals In Q3?

Q3 Results: How Will Be The Results Of Glenmark Pharmaceuticals In Q3?

Fri, Feb 10, 2023

How will be the results of Glenmark Pharmaceuticals in Q3? How will be the profit and margin in Q3? Know full details from Nupur.

Glenmark Pharma inks settlement pact with Pfizer for cancer drug

Glenmark Pharma inks settlement pact with Pfizer for cancer drug

Tue, Nov 22, 2022

Shares of of the drug maker were trading 1.54 per cent up at Rs 417.9 apiece on BSE.

Glenmark Pharma launches drug for diabetic patients with comorbidities

Glenmark Pharma launches drug for diabetic patients with comorbidities

Thu, Oct 20, 2022

"Diabetes is growing in India at an alarming rate, and eight out of every ten diabetic patients suffer from comorbidities," Glenmark Pharmaceuticals EVP & Business Head India Formulations Alok Malik said.

Glenmark launches drug to treat patients with insulin-resistant diabetes

Glenmark launches drug to treat patients with insulin-resistant diabetes

Thu, Oct 06, 2022

The Mumbai-based drug firm has launched the medication under the brand name LOBG and is priced at around Rs 10 per tablet.

Glenmark Pharma launches asthma drug Indamet

Glenmark Pharma launches asthma drug Indamet

Thu, Jun 16, 2022

Asthma affects more than 34 million people in India, causing thousands of deaths every year.

Glenmark Pharma gets final USFDA approval for generic version of Abiraterone Acetate tabs; shares gain

Glenmark Pharma gets final USFDA approval for generic version of Abiraterone Acetate tabs; shares gain

Fri, May 20, 2022

Glenmark Pharmaceuticals Ltd on Friday said that its US arm has received final approval from the US health regulator for its generic version of Abiraterone Acetate tablets used for the treatment of prostate cancer

Glenmark Life Sciences make lukewarm debut on exchanges: Share listed as per Anil Singhvi’s expectations- Check details

Glenmark Life Sciences make lukewarm debut on exchanges: Share listed as per Anil Singhvi’s expectations- Check details

Fri, Aug 06, 2021

Glenmark Life Sciences is an API subsidiary of Glenmark Pharma, as 40 per cent of its business comes from the parent company.

Glenmark Life Sciences IPO to open next week - What investors should know

Glenmark Life Sciences IPO to open next week - What investors should know

Tue, Jul 20, 2021

The proposed offer will have fresh issue worth up to Rs 1,060 crore and sale of up to 63 lakh equity shares by Glenmark Pharma. The offer will open on July 27, 2021 and close on July 29.

Top Stocks To Buy Today: Bajaj Finance, Glenmark Pharma, PNC Infra to Sterlite Technologies - 20 shares to earn bumper returns

Top Stocks To Buy Today: Bajaj Finance, Glenmark Pharma, PNC Infra to Sterlite Technologies - 20 shares to earn bumper returns

Mon, Aug 17, 2020

Stocks To Buy Today: As we begin a new week with hopes of earning good money after a negative closing on Friday, it is important for investors to know what may work for them today. Zee Business brings a list of 20 such stocks which have the potential to earn bumper returns

Glenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patients

Glenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patients

Tue, May 12, 2020

Glenmark Pharmaceuticals on Tuesday said it has initiated Phase 3 clinical trials on antiviral drug Favipiravir to check its efficacy on COVID-19 patients in India

Glenmark Pharma gets USFDA nod for cholesterol lowering drug

Glenmark Pharma gets USFDA nod for cholesterol lowering drug

Fri, Jun 28, 2019

Glenmark Pharmaceuticals Friday said it has received final approval from the US health regulator for Ezetimibe and Simvastatin tablets, used for treating high levels of cholesterol in the blood.

Top 5 stocks in focus on August 8: Glenmark, Merck to Techno Electric, here are the 5 newsmakers of the day

Top 5 stocks in focus on August 8: Glenmark, Merck to Techno Electric, here are the 5 newsmakers of the day

Wed, Aug 08, 2018

Glenmark Pharmaceuticals has received final approval from the US health regulator, USFDA, for Colesevelam Hydrochloride for oral suspension, used to lower cholesterol levels in the blood. The approved product is a generic version of Daiichi Sankyo Inc’s Welchol.

From HCL Tech, Maruti Suzuki to PVR, here are 5 stock picks for the week

From HCL Tech, Maruti Suzuki to PVR, here are 5 stock picks for the week

Sun, Jun 10, 2018

CPI, WPI and IIP will be presented in upcoming week and domestic indices will move as per the performances of these indicators.

Glenmark share price hits 52-week low, tanks 9% post Q4 FY18 results

Glenmark share price hits 52-week low, tanks 9% post Q4 FY18 results

Wed, May 30, 2018

Glenmark said results are not comparable to the corresponding quarter of the previous year, as the company through its partner Endo had launched Ezetimibe in the US in December 2016 and was entitled to an exclusivity on the product.

How Glenmark Pharma won this Candid Powder battle against lookalike rival

How Glenmark Pharma won this Candid Powder battle against lookalike rival

Thu, May 24, 2018

Pharma company Glenmark Pharmaceuticals, which manufactures and sells Candid Dusting Powder, has recently won a trademark and copyright battle in the Bombay High Court, against a lookalike brand, which sold a dusting powder by the name ‘Candidat’.

Post GST domestic pharma companies to face headwinds in 1HFY18

Post GST domestic pharma companies to face headwinds in 1HFY18

Mon, Jun 05, 2017

It has been a long and dreary quarter for pharmaceutical companies in Q4 wherein most posted a decline in net profit and things are not looking too good for the Indian pharma companies in the first half of FY18 as well.

Glenmark Pharmaceuticals receives ANDA approval for Atomoxetine capsule

Glenmark Pharmaceuticals receives ANDA approval for Atomoxetine capsule

Wed, May 31, 2017

The Glenmark Pharmaceuticals has been granted permission by the United States Food & Drug Administration (U.S. FDA) for Atomoxetine capsules.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x